Literature DB >> 20682905

Prediction, assessment of the Rift Valley fever activity in East and Southern Africa 2006-2008 and possible vector control strategies.

Assaf Anyamba1, Kenneth J Linthicum, Jennifer Small, Seth C Britch, Edwin Pak, Stephane de La Rocque, Pierre Formenty, Allen W Hightower, Robert F Breiman, Jean-Paul Chretien, Compton J Tucker, David Schnabel, Rosemary Sang, Karl Haagsma, Mark Latham, Henry B Lewandowski, Salih Osman Magdi, Mohamed Ally Mohamed, Patrick M Nguku, Jean-Marc Reynes, Robert Swanepoel.   

Abstract

Historical outbreaks of Rift Valley fever (RVF) since the early 1950s have been associated with cyclical patterns of the El Niño/Southern Oscillation (ENSO) phenomenon, which results in elevated and widespread rainfall over the RVF endemic areas of Africa. Using satellite measurements of global and regional elevated sea surface temperatures, elevated rainfall, and satellite derived-normalized difference vegetation index data, we predicted with lead times of 2-4 months areas where outbreaks of RVF in humans and animals were expected and occurred in the Horn of Africa, Sudan, and Southern Africa at different time periods from September 2006 to March 2008. Predictions were confirmed by entomological field investigations of virus activity and by reported cases of RVF in human and livestock populations. This represents the first series of prospective predictions of RVF outbreaks and provides a baseline for improved early warning, control, response planning, and mitigation into the future.

Entities:  

Mesh:

Year:  2010        PMID: 20682905      PMCID: PMC2913499          DOI: 10.4269/ajtmh.2010.09-0289

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

1.  Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya.

Authors:  K J Linthicum; A Anyamba; C J Tucker; P W Kelley; M F Myers; C J Peters
Journal:  Science       Date:  1999-07-16       Impact factor: 47.728

2.  Pretreatment of floodwater Aedes habitats (dambos) in Kenya with a sustained-release formulation of methoprene.

Authors:  T M Logan; K J Linthicum; J N Wagateh; P C Thande; C W Kamau; C R Roberts
Journal:  J Am Mosq Control Assoc       Date:  1990-12       Impact factor: 0.917

3.  Isolation of Rift Valley fever virus from mosquitoes (Diptera: Culicidae) collected during an outbreak in domestic animals in Kenya.

Authors:  T M Logan; K J Linthicum; F G Davies; Y S Binepal; C R Roberts
Journal:  J Med Entomol       Date:  1991-03       Impact factor: 2.278

4.  Prediction of a Rift Valley fever outbreak.

Authors:  Assaf Anyamba; Jean-Paul Chretien; Jennifer Small; Compton J Tucker; Pierre B Formenty; Jason H Richardson; Seth C Britch; David C Schnabel; Ralph L Erickson; Kenneth J Linthicum
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-14       Impact factor: 11.205

5.  Using adult mosquitoes to transfer insecticides to Aedes aegypti larval habitats.

Authors:  Gregor J Devine; Elvira Zamora Perea; Gerry F Killeen; Jeffrey D Stancil; Suzanne J Clark; Amy C Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-26       Impact factor: 11.205

6.  Evaluation of barrier treatments on native vegetation in a southern California desert habitat.

Authors:  Seth C Britch; Kenneth J Linthicum; Wayne W Wynn; Todd W Walker; Muhammad Farooq; Vincent L Smith; Cathy A Robinson; Branka B Lothrop; Melissa Snelling; Arturo Gutierrez; Hugh D Lothrop
Journal:  J Am Mosq Control Assoc       Date:  2009-06       Impact factor: 0.917

7.  Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya.

Authors:  K J Linthicum; F G Davies; A Kairo; C L Bailey
Journal:  J Hyg (Lond)       Date:  1985-08

8.  Toxicity of delta-phenothrin and resmethrin to non-target insects.

Authors:  Frank B Antwi; Robert Kd Peterson
Journal:  Pest Manag Sci       Date:  2009-03       Impact factor: 4.845

9.  Efficacy of aerial spraying of mosquito adulticide in reducing incidence of West Nile Virus, California, 2005.

Authors:  Ryan M Carney; Stan Husted; Cynthia Jean; Carol Glaser; Vicki Kramer
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

  9 in total
  77 in total

1.  Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.

Authors:  John C Morrill; Richard C Laughlin; Nandadeva Lokugamage; Jing Wu; Roberta Pugh; Pooja Kanani; L Garry Adams; Shinji Makino; C J Peters
Journal:  Vaccine       Date:  2013-08-27       Impact factor: 3.641

2.  Climate Influence on Emerging Risk Areas for Rift Valley Fever Epidemics in Tanzania.

Authors:  Clement N Mweya; Leonard E G Mboera; Sharadhuli I Kimera
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

3.  A model for the coupling of the Greater Bairam and local environmental factors in promoting Rift-Valley Fever epizootics in Egypt.

Authors:  H Gil; W A Qualls; C Cosner; D L DeAngelis; A Hassan; A M Gad; S Ruan; S R Cantrell; J C Beier
Journal:  Public Health       Date:  2015-08-19       Impact factor: 2.427

4.  Extended protection against phlebovirus infection conferred by recombinant adenovirus expressing consensus interferon (DEF201).

Authors:  Brian B Gowen; Jane Ennis; Eric J Sefing; Min-Hui Wong; Kie-Hoon Jung; Jeffrey D Turner
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

5.  Circulation of Rift Valley Fever Virus Antibody in Cattle during Inter-Epizootic/Epidemic Periods in Selected Regions of Tanzania.

Authors:  Linda Peniel Salekwa; Philemon Nyangi Wambura; Mirende Kichuki Matiko; Douglas M Watts
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

6.  Molecular detection of Rift Valley fever virus in serum samples from selected areas of Tanzania.

Authors:  Augustino Alfred Chengula; Christopher Jacob Kasanga; Robinson Hammerthon Mdegela; Raphael Sallu; Mmeta Yongolo
Journal:  Trop Anim Health Prod       Date:  2014-01-24       Impact factor: 1.559

7.  Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.

Authors:  John C Morrill; Richard C Laughlin; Nandadeva Lokugamage; Roberta Pugh; Elena Sbrana; William J Weise; L Garry Adams; Shinji Makino; C J Peters
Journal:  Vaccine       Date:  2012-11-12       Impact factor: 3.641

8.  Rift Valley Fever - assessment of effectiveness of surveillance and control measures in the EU.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Klaus Depner; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Paolo Pasquali; Helen Clare Roberts; Liisa Helena Sihvonen; Karl Stahl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Simon Gubbins; Sotiria-Eleni Antoniou; Alessandro Broglia; Josè Cortiñas Abrahantes; Sofie Dhollander; Yves Van der Stede
Journal:  EFSA J       Date:  2020-11-05

9.  RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge.

Authors:  Megan E Ermler; Ekaterina Yerukhim; Jill Schriewer; Stefan Schattgen; Zachary Traylor; Adam R Wespiser; Daniel R Caffrey; Zhijian J Chen; Charles H King; Michael Gale; Marco Colonna; Katherine A Fitzgerald; R Mark L Buller; Amy G Hise
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

10.  Drivers of Rift Valley fever epidemics in Madagascar.

Authors:  Renaud Lancelot; Marina Béral; Vincent Michel Rakotoharinome; Soa-Fy Andriamandimby; Jean-Michel Héraud; Caroline Coste; Andrea Apolloni; Cécile Squarzoni-Diaw; Stéphane de La Rocque; Pierre B H Formenty; Jérémy Bouyer; G R William Wint; Eric Cardinale
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.